PERSONAL: Feasibility Study Protocol for Placebo-Controlled, Randomized n-of-1 Trials of Tamsulosin for Lower Urinary Tract Symptoms

Background: Lower urinary tract symptoms (LUTS) affect more than half of men over age 70 and contribute to both poor health-related quality of life and polypharmacy. Tamsulosin hydrochloride, a selective α(1)-blocker, is the most common medication used to treat LUTS due to presumed benign prostatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Scott R., Breyer, Benjamin N., Oni-Orisan, Akinyemi, Steinman, Michael A., Sim, Ida, McCulloch, Charles E., Kenfield, Stacey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Digital Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521798/
https://www.ncbi.nlm.nih.gov/pubmed/34713020
http://dx.doi.org/10.3389/fdgth.2020.00007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521798/
https://www.ncbi.nlm.nih.gov/pubmed/34713020
http://dx.doi.org/10.3389/fdgth.2020.00007

Ejemplares similares